Kate Lapane to Psychotropic Drugs
This is a "connection" page, showing publications Kate Lapane has written about Psychotropic Drugs.
Lapane KL, Hunnicutt JN, Tjia J. Appropriateness of Psychopharmaco-logical Medication. J Am Geriatr Soc. 2015 Apr; 63(4):832-4.
Patterson SM, Hughes CM, Crealey G, Cardwell C, Lapane KL. An evaluation of an adapted U.S. model of pharmaceutical care to improve psychoactive prescribing for nursing home residents in northern ireland (fleetwood northern ireland study). J Am Geriatr Soc. 2010 Jan; 58(1):44-53.
Hughes CM, Lapane KL. Administrative initiatives for reducing inappropriate prescribing of psychotropic drugs in nursing homes: how successful have they been? Drugs Aging. 2005; 22(4):339-51.
Lapane KL, Zierler S, Lasater TM, Barbour MM, Carleton R, Hume AL. Is the use of psychotropic drugs associated with increased risk of ischemic heart disease? Epidemiology. 1995 Jul; 6(4):376-81.
Hughes CM, Lapane KL, Mor V, Ikegami N, Jónsson PV, Ljunggren G, Sgadari A. The impact of legislation on psychotropic drug use in nursing homes: a cross-national perspective. J Am Geriatr Soc. 2000 Aug; 48(8):931-7.
VanHaaren AM, Lapane KL, Hughes CM. Effect of triplicate prescription policy on benzodiazepine administration in nursing home residents. Pharmacotherapy. 2001 Oct; 21(10):1159-66.